Search Results

Reboot antibiotics arsenal at any cost.

• Authors : Mackenzie, Debora

Subjects: DRUG resistance in microorganisms; ANTIBIOTICS; DRUG development

• Source: New Scientist. 5/24/2014, Vol. 222 Issue 2970, p10-11. 2p.

Record details

Cause marketing exhaustion.

• Authors : Benson, Sally

Subjects: *SOCIAL marketing; *THERAPEUTICS; *FINANCE of pharmaceutical research

• Source: American Nurseryman. Nov2011, Vol. 211 Issue 11, p4-4. 1p. 2 Black and White Photographs.

Record details

Applied Science & Technology Full Text (H.W. Wilson)

Record details

WHO plans for neglected diseases are wrong.

• Authors : Moran, Mary

Subjects: WORLD Health Organization; PILOT projects; RESEARCH & development projects

• Source: Nature. 2/20/2014, Vol. 506 Issue 7488, p267-267. 1p.

Record details

Atlas neurological upstart Disarm gains $30M, AbbVie backing.

• Authors : Adams, Ben

Subjects: *BIOTECHNOLOGY; *FINANCE; DRUG development

• Source: FierceBiotech. 9/19/2017, p1-1. 1p.

Record details

Don't Forget the Orphans.

• Authors : Grewal, Jasjote; Hoppe, Nils

Subjects: RARE diseases; HEALTH services accessibility; MEDICAL care costsEUROPEEUROPEAN Commission

• Source: European Journal of Health Law; Apr2015, Vol. 22 Issue 2, p107-111, 5p

Record details

Applied Science & Technology Full Text (H.W. Wilson)

Record details

Disease or cure?

Subjects: FINANCE; MEDICAL research; FINANCE of pharmaceutical research

• Source: Economist. 1/26/2013, Vol. 406 Issue 8820, p67-67. 1/2p.

Record details

Medgenics Reports 2nd Qtr Financial Results.

Subjects: FINANCIAL statements; PHARMACEUTICAL industry finance; RESEARCH & development financeMEDGENICS Inc.

• Source: Biomedical Market Newsletter; 8/12/2011, Vol. 21, p14-16, 3p

Record details

Applied Science & Technology Full Text (H.W. Wilson)

Record details